SEC Form 4 · accession 0001624073-17-000009
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alistair Macdonald
Officer — Chief Executive Officer · Director
Period of report
Aug 10, 2017
Accepted (ET)
Aug 14, 2017 · 7:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Restricted Stock UnitsF1 | — | Aug 10, 2017 | A | 36,429 | A | — | — | Class A Common Stock | 36,429 | 36,429 | D |
Explanation of responses
- F1Each performance restricted stock unit ("PRSU") represents a contingent right to receive one share of Issuer common stock. The PRSUs cliff vest on January 1, 2021 upon the achievement of $100 million of defined synergy savings on an annual run-rate through December 31, 2020.